Skip to main content
Livermore
Livermore
ZHEN

Bicara Therapeutics Inc.

BCAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002023658

In the last 90 days, Bicara Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 171 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Bicara Therapeutics Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of BCAX: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders6984+15
Shares36.4M46.7M+10.3M (+28.3%)
Value$927.6M$813.6M−$114.0M (−12.3%)

New holders (39)

Institutions that held Bicara Therapeutics Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to BCAX in Q4 2024
InstitutionSharesValue% of portfolio
Red Tree Management, LLC3,170,509$55.2M36.35%
BlackRock, Inc.1,261,601$22.0M0.00%
Foresite Capital Management VI LLC950,000$16.5M7.37%
Acorn Capital Advisors, LLC643,381$11.2M6.03%
State Street Corp304,731$5.31M0.00%
Northern Trust Corp159,043$2.77M0.00%
Charles Schwab Investment Management Inc156,784$2.73M0.00%
Boxer Capital Management, LLC135,000$2.35M0.20%
Deutsche Bank AG112,476$1.96M0.00%
DAFNA Capital Management LLC105,500$1.84M0.47%
Marshall Wace, LLP67,733$1.18M0.00%
Bank of New York Mellon Corp40,268$701.5K0.00%
Skandinaviska Enskilda Banken AB (publ)38,035$646.6K0.00%
XTX Topco Ltd27,334$476.2K0.04%
Nuveen Asset Management, LLC25,028$436.0K0.00%
Verition Fund Management LLC21,630$376.8K0.00%
Wexford Capital LP20,000$348.4K0.09%
Rhumbline Advisers19,008$331.1K0.00%
Invesco Ltd.15,324$266.9K0.00%
LMR Partners LLP15,150$263.9K0.00%
MetLife Investment Management12,163$211.9K0.00%
Mirae Asset Global ETFs Holdings Ltd.10,907$190.0K0.00%
Wells Fargo & Company10,027$174.7K0.00%
Corebridge Financial, Inc.9,597$167.2K0.00%
SG Americas Securities, LLC8,411$147.0K0.00%
Virtus ETF Advisers LLC3,939$68.6K0.03%
Police & Firemen's Retirement System of New Jersey3,692$64.3K0.00%
STRS Ohio3,600$62.7K0.00%
Ameritas Investment Partners, Inc.2,019$35.2K0.00%
Legal & General Group Plc1,923$33.4K0.00%
BNP Paribas Arbitrage, SA1,830$31.9K0.00%
Spire Wealth Management1,804$31.4K0.00%
California State Teachers Retirement System1,426$24.8K0.00%
Tower Research Capital LLC (TRC)1,056$18.4K0.00%
R Squared Ltd1,040$18.1K0.02%
Amalgamated Bank658$11.0K0.00%
Sterling Capital Management LLC276$4.81K0.00%
Caitong International Asset Management Co., Ltd76$1.32K0.00%
GAMMA Investing LLC59$1.03K0.00%

Sold out (24)

Institutions that held Bicara Therapeutics Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of BCAX in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Logos Global Management LP800,000$20.4M
Point72 Asset Management, L.P.371,962$9.47M
Citadel Advisors LLC234,122$5.96M
Iron Triangle Partners LP200,000$5.09M
Ameriprise Financial Inc200,000$5.09M
Boxer Capital, LLC135,000$3.44M
Nicholas Investment Partners, LP117,523$2.99M
Alyeska Investment Group, L.P.72,807$1.85M
Point72 (DIFC) Ltd55,757$1.42M
Squarepoint Ops LLC44,774$1.14M
ADAR1 Capital Management, LLC40,440$1.03M
Samsara BioCapital, LLC35,000$891.5K
Walleye Capital LLC31,780$809.4K
Soros Fund Management LLCSuperinvestorSoros Fund Management20,000$509.4K
Point72 Asia (Singapore) Pte. Ltd.18,125$461.6K
Scientech Research LLC17,973$457.8K
New York State Common Retirement Fund17,227$438.8K
Legato Capital Management LLC14,179$361.1K
Teachers Retirement System of the State of Kentucky14,039$358.0K
Greenland Capital Management LP12,296$313.2K
Jane Street Group, LLC12,151$309.5K
Davidson Kempner Capital Management LP10,000$255.1K
Ghisallo Capital Management LLC10,000$254.7K
Two Sigma Investments, LP9,000$229.2K